Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wharton's Jelly for Knee Osteoarthritis
NCT04711304Phase 2Not yet recruiting
- Sponsor
- BioIntegrate
- Start
- Jan 2023
- Primary completion
- Jun 2026
- Modality
- Lipid-based Nanoparticles, Cell Therapies
01
Overview
A Phase 2 trial of GeneXSTEM in osteoarthritis (OA), sponsored by BioIntegrate. Planned start Jan 2023; status: not yet recruiting.
02
Drugs
GeneXSTEM
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04711304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04711304.